Vécsei L - Search Results

1

Real-world operation of multiple sclerosis centres in Central-Eastern European countries covering 107 million inhabitants.

Kokas Z, Járdánházy A, Sandi D, Biernacki T, Fricska-Nagy Z, Füvesi J, Bartosik-Psujek H, Kes VB, Berger T, Berthele A, Drulovic J, Hemmer B, Horakova D, Ledinek AH, Havrdova EK, Magyari M, Rejdak K, Tiu C, Turcani P, Klivényi P, Kincses ZT, Vécsei L, Bencsik K. Kokas Z, et al. Among authors: vecsei l. Mult Scler Relat Disord. 2023 Jan;69:104406. doi: 10.1016/j.msard.2022.104406. Epub 2022 Nov 8. Mult Scler Relat Disord. 2023. PMID: 36413917 Review.

2

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension.

Mantegazza R, Wolfe GI, Muppidi S, Wiendl H, Fujita KP, O'Brien FL, Booth HDE, Howard JF Jr; REGAIN Study Group. Mantegazza R, et al. Neurology. 2021 Jan 26;96(4):e610-e618. doi: 10.1212/WNL.0000000000011207. Epub 2020 Nov 23. Neurology. 2021. PMID: 33229455 Free PMC article. Clinical Trial.

3

Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab: subgroup analysis of REGAIN and its extension study.

Siddiqi ZA, Nowak RJ, Mozaffar T, O'Brien F, Yountz M, Patti F; REGAIN Study Group. Siddiqi ZA, et al. Muscle Nerve. 2021 Dec;64(6):662-669. doi: 10.1002/mus.27422. Epub 2021 Oct 14. Muscle Nerve. 2021. PMID: 34590717 Clinical Trial.

4

Sensitivity of Rodent Microglia to Kynurenines in Models of Epilepsy and Inflammation In Vivo and In Vitro: Microglia Activation is Inhibited by Kynurenic Acid and the Synthetic Analogue SZR104.

Lajkó N, Kata D, Szabó M, Mátyás A, Dulka K, Földesi I, Fülöp F, Gulya K, Vécsei L, Mihály A. Lajkó N, et al. Among authors: vecsei l. Int J Mol Sci. 2020 Dec 7;21(23):9333. doi: 10.3390/ijms21239333. Int J Mol Sci. 2020. PMID: 33297593 Free PMC article.

5

A genome-wide screen for association in Hungarian multiple sclerosis.

Rajda C, Bencsik K, Seres E, Jonasdottir A, Foltynie T, Sawcer S, Benediktsson K, Fossdal R, Setakis E, Compston A, Vécsei L. Rajda C, et al. Among authors: vecsei l. J Neuroimmunol. 2003 Oct;143(1-2):84-7. doi: 10.1016/j.jneuroim.2003.08.017. J Neuroimmunol. 2003. PMID: 14575920

6

Alpha-tocopherol and NADPH in the erythrocytes and plasma of multiple sclerosis patients. Effect of interferon-beta-1b treatment.

Karg E, Klivenyi P, Bencsik K, Turi S, Vecsei L. Karg E, et al. Among authors: vecsei l. Eur Neurol. 2003;50(4):215-9. doi: 10.1159/000073862. Eur Neurol. 2003. PMID: 14634265

7

Comparative study on the effects of kynurenic acid and glucosamine-kynurenic acid.

Füvesi J, Somlai C, Németh H, Varga H, Kis Z, Farkas T, Károly N, Dobszay M, Penke Z, Penke B, Vécsei L, Toldi J. Füvesi J, et al. Among authors: vecsei l. Pharmacol Biochem Behav. 2004 Jan;77(1):95-102. doi: 10.1016/j.pbb.2003.10.001. Pharmacol Biochem Behav. 2004. PMID: 14724046

8

Kynurenines in neurodegenerative disorders: therapeutic consideration.

Klivényi P, Toldi J, Vécsei L. Klivényi P, et al. Among authors: vecsei l. Adv Exp Med Biol. 2004;541:169-83. doi: 10.1007/978-1-4419-8969-7_10. Adv Exp Med Biol. 2004. PMID: 14977214 Review. No abstract available.

9

[Clinical features and diagnosis of spinocerebellar ataxia].

Klivényi P, Horváth Z, Vécsei L. Klivényi P, et al. Among authors: vecsei l. Ideggyogy Sz. 2004 Jan 20;57(1-2):11-22. Ideggyogy Sz. 2004. PMID: 15042864 Review. Hungarian.

10

Kynurenine metabolism in plasma and in red blood cells in Parkinson's disease.

Hartai Z, Klivenyi P, Janaky T, Penke B, Dux L, Vecsei L. Hartai Z, et al. Among authors: vecsei l. J Neurol Sci. 2005 Dec 15;239(1):31-5. doi: 10.1016/j.jns.2005.07.006. Epub 2005 Aug 15. J Neurol Sci. 2005. PMID: 16099471

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

699 results

Search Page